Literature DB >> 9864667

Protocol biopsies in renal transplantation: research tool or clinically useful?

D N Rush1, P Nickerson, J R Jeffery, R M McKenna, P C Grimm, J Gough.   

Abstract

Early protocol biopsies of stable, well functioning renal allografts reveal a high prevalence of clinically unsuspected acute and chronic pathology. It is becoming increasingly apparent that these histopathological findings are both pathogenic and predictive of long-term allograft outcome. Therefore, protocol biopsies may be required for optimal post-transplant surveillance until non-invasive methods to detect allograft inflammation are developed.

Entities:  

Mesh:

Year:  1998        PMID: 9864667     DOI: 10.1097/00041552-199811000-00012

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  5 in total

1.  Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.

Authors:  Luis F Quintana; Josep M Campistol; Maria P Alcolea; Elisenda Bañon-Maneus; Amandaé Sol-González; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

2.  Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection.

Authors:  A J Matas; A Humar; W D Payne; K J Gillingham; D L Dunn; D E Sutherland; J S Najarian
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

3.  An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis.

Authors:  R Shapiro; P Randhawa; M L Jordan; V P Scantlebury; C Vivas; A Jain; R J Corry; J McCauley; J Johnston; J Donaldson; E A Gray; I Dvorchik; T R Hakala; J J Fung; T E Starzl
Journal:  Am J Transplant       Date:  2001-05       Impact factor: 8.086

4.  Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes.

Authors:  Stuart M Flechner; Sunil M Kurian; Steven R Head; Starlette M Sharp; Thomas C Whisenant; Jie Zhang; Jeffrey D Chismar; Steve Horvath; Tony Mondala; Timothy Gilmartin; Daniel J Cook; Steven A Kay; John R Walker; Daniel R Salomon
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

5.  Subclinical toxicity of calcineurin inhibitors in repeated protocol biopsies: an independent risk factor for chronic kidney allograft damage.

Authors:  Karel Krejcí; Tomás Tichý; Miroslav Hrubý; Pavel Horák; Hana Ciferská; Vladko Horcicka; Pavel Strebl; Sadek Al-Jabry; Petr Bachleda; Josef Zadrazil
Journal:  Transpl Int       Date:  2009-11-09       Impact factor: 3.782

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.